Cellumed
Cellumed is a South Korea–based biotechnology and medical-device company focused on tissue regeneration, orthopedic medical devices and biomaterials, recombinant growth factor development and scale-up, and enzymes for mRNA vaccine/therapeutics. The company operates a tissue bank, maintains an active patent portfolio with multiple technical methods and device patents, publishes peer-reviewed research, and reports activities in device manufacturing, bioprocess scale-up and AI-assisted R&D.
Industries
Nr. of Employees
medium (51-250)
Patents
Products
Demineralized bone matrix (DBM) gel
A gel-formulated demineralized bone matrix intended as a bone graft substitute for bone defect filling.
Recombinant BMP2 product
A recombinant bone morphogenetic protein product intended to promote osteogenesis for use in bone-regeneration applications.
Biological meniscus graft
An implantable meniscus graft product intended for meniscal repair and regeneration.
Demineralized bone matrix (DBM) gel
A gel-formulated demineralized bone matrix intended as a bone graft substitute for bone defect filling.
Recombinant BMP2 product
A recombinant bone morphogenetic protein product intended to promote osteogenesis for use in bone-regeneration applications.
Biological meniscus graft
An implantable meniscus graft product intended for meniscal repair and regeneration.
Services
Processing, preparation and distribution of human tissue grafts and supply of tissue-engineering inputs.
Joint development projects with external contract development and manufacturing organizations for enzyme proteins used in mRNA production and other biologics.
Manufacturing and supply of orthopedic devices, surgical guides and implantable biomaterial products for clinical use.
Research partnerships, publications and joint projects in tissue engineering, biomaterials and recombinant protein production.
Processing, preparation and distribution of human tissue grafts and supply of tissue-engineering inputs.
Joint development projects with external contract development and manufacturing organizations for enzyme proteins used in mRNA production and other biologics.
Manufacturing and supply of orthopedic devices, surgical guides and implantable biomaterial products for clinical use.
Research partnerships, publications and joint projects in tissue engineering, biomaterials and recombinant protein production.
Expertise Areas
- Tissue regeneration and tissue banking
- Orthopedic implants and surgical guides
- Biomaterials and scaffold fabrication
- Recombinant growth factor production and purification
Key Technologies
- Recombinant protein production
- Monoclonal clone selection and serum-free cell culture
- Bioprocess scale-up
- Protein purification methods for growth factors
News & Updates
Company reported ISO 13485 re-certification for its medical-device production facilities.
Company reported successful performance evaluation of RNA production enzymes intended for mRNA vaccine/therapeutic manufacture.
Company announced a patent filing for a melittin-based RNA-LNP vaccine with intranasal administration data reported.
Announcement of sample development completion for enzymes used in mRNA vaccine and therapeutic manufacture.
Company reported attainment of monthly production-volume records for bone graft products.
Company reported ISO 13485 re-certification for its medical-device production facilities.
Company reported successful performance evaluation of RNA production enzymes intended for mRNA vaccine/therapeutic manufacture.
Company announced a patent filing for a melittin-based RNA-LNP vaccine with intranasal administration data reported.
Announcement of sample development completion for enzymes used in mRNA vaccine and therapeutic manufacture.
Company reported attainment of monthly production-volume records for bone graft products.